Veralto Corp
VLTO
95.73
-0.72
-0.75%
Veralto Corp
US · VLTO
#843 by market cap
Listed 2023
95.73
-0.72
-0.75%
Live - 5344 symbols - heartbeat 221s ago
· 2026-10-08 07:41
Pre-market
95.73
0.00%
After-hours
95.73
0.00%
- Market cap
- 23.34B
- P/E (TTM)i
- 24.11
- P/Bi
- 7.54
- EPSi
- 3.76
- Div yieldi
- 0.52%
- 52W posi
- 63%
Reader sentiment
Are you bullish or bearish on VLTO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.85, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 6 years
Latest year +5.97% YoY
Margins
- Gross margin
- 59.95%
- Operating margin
- 23.21%
- Net margin
- 17.08%
Key ratios & quality
- Enterprise valuei
- 24.03B
- PEG ratioi
- 6.67
- Altman Z-Scorei
- 4.85
PEG uses trailing P/E against the 3-year net income growth rate (3.62%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 4.35B | 4.70B | 4.87B | 5.02B | 5.19B | 5.50B |
| Gross profit | 2.51B | 2.71B | 2.76B | 2.90B | 3.11B | 3.30B |
| Selling & admin expenses | 1.34B | 1.43B | 1.43B | 1.54B | 1.64B | 1.76B |
| Research & development | 219.00M | 244.00M | 217.00M | 225.00M | 253.00M | 266.00M |
| Operating profit | 951.00M | 1.04B | 1.11B | 1.14B | 1.21B | 1.28B |
| Pretax profit | 950.00M | 1.05B | 1.11B | 1.10B | 1.09B | 1.17B |
| Tax | 226.00M | 186.00M | 268.00M | 257.00M | 253.00M | 233.00M |
| Net profit | 724.00M | 861.00M | 845.00M | 839.00M | 833.00M | 940.00M |
| Basic EPS | 3 | 4 | 3 | 3 | 3 | 4 |
| Diluted EPS | 2.93 | 3.49 | 3.43 | 3.40 | 3.34 | 3.76 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 1.33B | 1.37B | 1.40B | 1.40B | 1.42B | 1.47B |
| Gross profit | 805.00M | 822.00M | 844.00M | 828.00M | 854.00M | 902.00M |
| Selling & admin expenses | 419.00M | 442.00M | 451.00M | 444.00M | 448.00M | 514.00M |
| Research & development | 64.00M | 67.00M | 67.00M | 68.00M | 68.00M | 73.00M |
| Operating profit | 322.00M | 313.00M | 326.00M | 316.00M | 338.00M | 315.00M |
| Pretax profit | 289.00M | 285.00M | 306.00M | 293.00M | 321.00M | 289.00M |
| Tax | 64.00M | 63.00M | 67.00M | 39.00M | 67.00M | 48.00M |
| Net profit | 225.00M | 222.00M | 239.00M | 254.00M | 254.00M | 241.00M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.90 | 0.89 | 0.95 | 1.01 | 1.02 | 0.98 |
Balance sheet
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total current assets | -- | 1.21B | 1.28B | 2.07B | 2.39B | 3.43B |
| Cash & ST investments | -- | -- | 0 | 762.00M | 1.10B | 2.03B |
| Inventory | -- | 322.00M | 345.00M | 297.00M | 288.00M | 307.00M |
| Total assets | -- | 4.84B | 4.83B | 5.69B | 6.41B | 7.69B |
| Total current liabilities | -- | 1.12B | 1.12B | 1.27B | 1.25B | 2.06B |
| Short-term debt | -- | 34.00M | 32.00M | 33.00M | 39.00M | 748.00M |
| Long-term debt | -- | -- | -- | 2.63B | 2.60B | 1.97B |
| Total liabilities | -- | 1,639,000,000.00 | 1,585,000,000.00 | 4,304,000,000.00 | 4,361,000,000.00 | 4,587,000,000.00 |
| Total equity | -- | 3.20B | 3.24B | 1.39B | 2.05B | 3.11B |
| Retained earnings | -- | -- | 0 | 178.00M | 917.00M | 1.74B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 2.56B | 2.95B | 3.20B | 3.43B | 2.94B | 3.65B |
| Cash & ST investments | 1.24B | 1.56B | 1.78B | 2.03B | 1.43B | 2.12B |
| Inventory | 310.00M | 329.00M | 340.00M | 307.00M | 332.00M | 336.00M |
| Total assets | 6.65B | 7.17B | 7.43B | 7.69B | 7.65B | 8.56B |
| Total current liabilities | 1.17B | 1.28B | 2.04B | 2.06B | 1.98B | 2.06B |
| Short-term debt | -- | -- | 700.00M | 748.00M | 700.00M | 700.00M |
| Long-term debt | 2.63B | 2.67B | 1.97B | 1.97B | 1.96B | 2.68B |
| Total liabilities | 4,336,000,000.00 | 4,510,000,000.00 | 4,581,000,000.00 | 4,587,000,000.00 | 4,647,000,000.00 | 5,460,000,000.00 |
| Total equity | 2.31B | 2.66B | 2.85B | 3.11B | 3.01B | 3.10B |
| Retained earnings | 1.11B | 1.31B | 1.52B | 1.74B | 1.97B | 2.18B |
Cash flow
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.00B | 896.00M | 870.00M | 963.00M | 875.00M | 1.08B |
| Depreciation & amortization | 110.00M | 106.00M | 90.00M | 87.00M | 78.00M | 78.00M |
| Free cash flow | 965.00M | 842.00M | 836.00M | 909.00M | 820.00M | 1.01B |
| Dividends paid | -- | -- | 0 | 0 | -89.00M | -109.00M |
| Stock buybacks / issuance | -844.00M | -800.00M | -781.00M | -147.00M | 0 | 0 |
| Ending cash balance | 0 | 0 | 0 | 762.00M | 1.10B | 2.03B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 157.00M | 339.00M | 270.00M | 311.00M | 182.00M | 340.00M |
| Depreciation & amortization | 19.00M | 19.00M | 20.00M | 20.00M | 24.00M | 29.00M |
| Free cash flow | 142.00M | 323.00M | 258.00M | 291.00M | 170.00M | 328.00M |
| Dividends paid | -27.00M | -27.00M | -28.00M | -27.00M | -32.00M | -32.00M |
| Stock buybacks / issuance | 0 | 13.00M | 7.00M | -20.00M | -300.00M | -129.00M |
| Ending cash balance | 1.24B | 1.56B | 1.78B | 2.03B | 1.43B | 2.12B |
Returns & efficiency
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| ROE %i | -- | 26.93 | 22.05 | 36.34 | 48.70 | 36.55 |
| ROA %i | -- | 17.79 | 14.67 | 15.95 | 13.77 | 13.33 |
| ROIC %i | -- | 25.84 | 24.51 | 22.93 | 20.52 | 18.85 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | 34.96 |
| EBIT margin %i | 21.87 | 22.28 | 22.12 | 22.43 | 23.09 | 23.06 |
| FCF / sales %i | 22.19 | 17.91 | 17.13 | 18.10 | 15.79 | 18.43 |
| Current ratioi | -- | 1.07 | 1.14 | 1.64 | 1.92 | 1.67 |
| Quick ratioi | -- | 0.68 | 0.73 | 1.26 | 1.54 | 1.42 |
| Debt / assetsi | -- | 2.79 | 2.55 | 48.78 | 43.19 | 37.42 |
| LT debt / equityi | -- | 3.16 | 2.81 | 198.41 | 133.86 | 68.63 |
| Interest coveragei | -- | -- | 7.39 | 37.53 | 10.61 | 13.22 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 4.91 | 3.38 | 4.16 |
| Net income CAGR (3Y) %i | -- | -- | -- | 5.04 | -1.10 | 3.62 |
| FCF CAGR (3Y) %i | -- | -- | -- | -1.97 | -0.88 | 6.65 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 46.19 | 41.35 | 38.03 | 36.55 | 36.52 | 34.37 |
| ROA %i | 14.15 | 13.66 | 13.34 | 13.33 | 13.55 | 12.56 |
| ROIC %i | 21.28 | 20.39 | 18.40 | 18.85 | 18.48 | 17.01 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 23.43 | 23.31 | 23.18 | 23.06 | 23.21 | 22.84 |
| FCF / sales %i | 16.29 | 17.59 | 18.09 | 18.43 | 18.63 | 18.38 |
| Current ratioi | 2.19 | 2.32 | 1.57 | 1.67 | 1.48 | 1.78 |
| Quick ratioi | 1.77 | 1.91 | 1.30 | 1.42 | 1.19 | 1.48 |
| Debt / assetsi | 39.58 | 37.26 | 35.97 | 37.42 | 34.78 | 39.48 |
| LT debt / equityi | 114.25 | 100.72 | 69.27 | 68.63 | 65.29 | 86.50 |
| Interest coveragei | 11.04 | 11.36 | 12.15 | 13.22 | 13.96 | 14.14 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Water quality is the largest reported line at 61.60% of revenue, across 2 reported segments.
- Product Quality & Innovation follows at 38.40%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Water quality61.60%
Product Quality & Innovation38.40%
Quote time 2026-10-08 07:41:58 · For reference only, not investment advice and not tailored to your situation.